Unified Trust Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$400K Hold
3,708
0.12% 65
2021
Q2
$418K Hold
3,708
0.12% 63
2021
Q1
$401K Hold
3,708
0.13% 60
2020
Q4
$415K Buy
3,708
+40
+1% +$3.84K 0.24% 45
2020
Q3
$321K Sell
3,668
-300
-8% -$28.2K 0.23% 45
2020
Q2
$389K Hold
3,968
0.29% 46
2020
Q1
$302K Hold
3,968
0.2% 47
2019
Q4
$351K Hold
3,968
0.22% 45
2019
Q3
$300K Hold
3,968
0.2% 49
2019
Q2
$288K Hold
3,968
0.2% 44
2019
Q1
$319K Buy
3,968
+75
+2% +$6.14K 0.24% 43
2018
Q4
$358K Buy
+3,893
New +$342K 0.33% 44

Other funds holding ABBV

Unified Trust Company's ABBV Position: Q3 2021 in Review

Unified Trust Company held its AbbVie (ABBV) position steady in Q3 2021 at 3,708 shares worth $400K. The position accounts for 0.12% of the portfolio, ranked #65.

Unified Trust Company first reported a position in ABBV in Q4 2018 and has held it in 12 quarters since. The position peaked at $418K in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Unified Trust Company held 3,708 shares of AbbVie worth $400K as of Q3 2021.
  • Unified Trust Company left its AbbVie share count unchanged in Q3 2021.
  • AbbVie made up 0.12% of Unified Trust Company's portfolio in Q3 2021, its #65 holding.
  • Unified Trust Company first reported a position in AbbVie in Q4 2018 and has held it in 12 quarters since.
  • Unified Trust Company's AbbVie position peaked at $418K in Q2 2021.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Unified Trust Company's 13F filing for Q3 2021, filed 23 Nov 2021.